"Located on Sand Canyon Avenue and Alton Parkway, just off the 405 freeway, this campus is an extension of Hoag's services in Newport Beach and its six Hoag Health Centers throughout Orange County. Hoag is dedicated to creating the best experience possible for our patients. This visitor information area provides information to help you and those close to you during a hospital stay. Hoag Hospital Irvine has joined Hoag Hospital Newport Beach as a designated Cardiovascular Receiving Center (CVRC), awarded by the Orange County Emergency Medical Services (OCEMS). With this designation, Irvine/South County residents can be taken to Hoag Hospital Irvine for emergency cardiac care."

During the past decade, Hoag Hospital - Irvine conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hoag Hospital - Irvine" #1 sponsor was "Hoag Memorial Hospital Presbyterian" with 4 trials, followed by "ALX Oncology Inc." with 2 trials sponsored, "Aethlon Medical Inc." with 1 trials sponsored, "Aivita Biomedical, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hoag Hospital - Irvine" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator, "Crohn's and Colitis Foundation" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hoag Hospital - Irvine" are "Head and Neck Cancer" (2 trials), "Head and Neck Squamous Cell Carcinoma" (2 trials), "Prostate Cancer" (2 trials), "Breast Cancer" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Hoag Hospital - Irvine" in a lesser frequency.

Most popular intervention types in "Hoag Hospital - Irvine" are "Drug" (6 trials), "Biological" (1 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evorpacept" (2 trials), "Pembrolizumab" (2 trials), "18F-fluoroestradiol PET/CT" (1 trials), "89Zr-daratumumab PET/CT" (1 trials) and "AV-MEL-1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hoag Hospital - Irvine" are 8 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hoag Hospital - Irvine". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hoag Hospital - Irvine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hoag Hospital - Irvine, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".